TY - JOUR
T1 - Assisted versus manual interpretation of low-dose CT scans for lung cancer screening
T2 - Impact on lung-RADS agreement
AU - Jacobs, Colin
AU - Schreuder, Anton
AU - van Riel, Sarah J.
AU - Scholten, Ernst Th
AU - Wittenberg, Rianne
AU - Wille, Mathilde M.Winkler
AU - de Hoop, Bartjan
AU - Sprengers, Ralf
AU - Mets, Onno M.
AU - Geurts, Bram
AU - Prokop, Mathias
AU - Schaefer-Prokop, Cornelia
AU - van Ginneken, Bram
N1 - Funding Information:
Disclosures of Conflicts of Interest: C.J. MeVis Medical Solutions (Bremen, Germany) supplied a research grant to conduct this study and allowed the use of their commercial CAD system; research grant from Thirona (Nijmegen, the Netherlands); institution received royalties from MeVis Medical Solutions for the development of Veolity, a reading platform for lung cancer screening. A.S. disclosed no relevant relationships. S.J.v.R. disclosed no relevant relationships. E.T.S. disclosed no relevant relationships. R.W. disclosed no relevant relationships. M.M.W.W. disclosed no relevant relationships. B.d.H. disclosed no relevant relationships. R.S. disclosed no relevant relationships. O.M.M. disclosed no relevant relationships. B.G. author’s institution receives consulting fee from Siemens Healthineers; stock/stock options in Clovis Oncology, Infinity Pharmaceuticals, CRISPR Therapeutics, Nanostring Technologies, and Bionano Genomics. M.P. disclosed no relevant relationships. C.S.P. royalties from Springer, Thieme, and Elsevier; payment or honoraria from Boehringer. B.v.G. grants from Thirona and MeVis Medical Solutions, Delft Imaging, Canon, Dutch Research Council, and European Union Funds; royalties from Thirona, MeVis Medical Solutions, and Delft Imaging; leadership or fiduciary role with Fleischner Society; stock/stock options in Thirona.
Funding Information:
Supported by a research grant from MeVis Medical Solutions, Bremen, Germany.
Publisher Copyright:
© RSNA, 2021.
PY - 2021/9
Y1 - 2021/9
N2 - Purpose: To compare the inter-and intraobserver agreement and reading times achieved when assigning Lung Imaging Reporting and Data System (Lung-RADS) categories to baseline and follow-up lung cancer screening studies by using a dedicated CT lung screening viewer with integrated nodule detection and volumetric support with those achieved by using a standard picture archiving and communication system (PACS)-like viewer. Materials and Methods: Data were obtained from the National Lung Screening Trial (NLST). By using data recorded by NLST radiologists, scans were assigned to Lung-RADS categories. For each Lung-RADS category (1 or 2, 3, 4A, and 4B), 40 CT scans (20 baseline scans and 20 follow-up scans) were randomly selected for 160 participants (median age, 61 years; interquartile range, 58–66 years; 61 women) in total. Seven blinded observers independently read all CT scans twice in a randomized order with a 2-week washout period: once by using the standard PACS-like viewer and once by using the dedicated viewer. Observers were asked to assign a Lung-RADS category to each scan and indicate the risk-dominant nodule. Inter-and intraobserver agreement was analyzed by using Fleiss k values and Cohen weighted k values, respectively. Reading times were compared by using a Wilcoxon signed rank test. Results: The interobserver agreement was moderate for the standard viewer and substantial for the dedicated viewer, with Fleiss k values of 0.58 (95% CI: 0.55, 0.60) and 0.66 (95% CI: 0.64, 0.68), respectively. The intraobserver agreement was substantial, with a mean Cohen weighted k value of 0.67. The median reading time was significantly reduced from 160 seconds with the standard viewer to 86 seconds with the dedicated viewer (P, .001). Conclusion: Lung-RADS interobserver agreement increased from moderate to substantial when using the dedicated CT lung screening viewer. The median reading time was substantially reduced when scans were read by using the dedicated CT lung screening viewer.
AB - Purpose: To compare the inter-and intraobserver agreement and reading times achieved when assigning Lung Imaging Reporting and Data System (Lung-RADS) categories to baseline and follow-up lung cancer screening studies by using a dedicated CT lung screening viewer with integrated nodule detection and volumetric support with those achieved by using a standard picture archiving and communication system (PACS)-like viewer. Materials and Methods: Data were obtained from the National Lung Screening Trial (NLST). By using data recorded by NLST radiologists, scans were assigned to Lung-RADS categories. For each Lung-RADS category (1 or 2, 3, 4A, and 4B), 40 CT scans (20 baseline scans and 20 follow-up scans) were randomly selected for 160 participants (median age, 61 years; interquartile range, 58–66 years; 61 women) in total. Seven blinded observers independently read all CT scans twice in a randomized order with a 2-week washout period: once by using the standard PACS-like viewer and once by using the dedicated viewer. Observers were asked to assign a Lung-RADS category to each scan and indicate the risk-dominant nodule. Inter-and intraobserver agreement was analyzed by using Fleiss k values and Cohen weighted k values, respectively. Reading times were compared by using a Wilcoxon signed rank test. Results: The interobserver agreement was moderate for the standard viewer and substantial for the dedicated viewer, with Fleiss k values of 0.58 (95% CI: 0.55, 0.60) and 0.66 (95% CI: 0.64, 0.68), respectively. The intraobserver agreement was substantial, with a mean Cohen weighted k value of 0.67. The median reading time was significantly reduced from 160 seconds with the standard viewer to 86 seconds with the dedicated viewer (P, .001). Conclusion: Lung-RADS interobserver agreement increased from moderate to substantial when using the dedicated CT lung screening viewer. The median reading time was substantially reduced when scans were read by using the dedicated CT lung screening viewer.
KW - Computer Applications-Detection/Diagnosis
KW - CT
KW - Lung
KW - Observer Performance
KW - Technology Assessment
KW - Thorax
UR - http://www.scopus.com/inward/record.url?scp=85120411755&partnerID=8YFLogxK
U2 - 10.1148/rycan.2021200160
DO - 10.1148/rycan.2021200160
M3 - Article
C2 - 34559005
AN - SCOPUS:85120411755
SN - 2638-616X
VL - 3
JO - Radiology: Imaging Cancer
JF - Radiology: Imaging Cancer
IS - 5
M1 - e200160
ER -